William Garrett Nichols's Insider Trades & SAST Disclosures
William Garrett Nichols's most recent trade in Candel Therapeutics Inc was a trade of 45,316 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on March 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William Garrett Nichols.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 Mar 2025 | 45,316 | 52,493 | - | 8.8 | 396,995 | Common Stock |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 13,905 | 31,095 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 18 Mar 2025 | 13,905 | 97,809 | - | 1.3 | 17,937 | Common Stock |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 18 Mar 2025 | 4,584 | 83,904 | - | 3.8 | 17,190 | Common Stock |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 4,584 | 195,416 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 107,250 | 107,250 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 10,428 | 79,320 | - | 7.2 | 75,342 | Common Stock |
| Candel Therapeutics Inc | Garrett William Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 13,935 | 100,547 | - | 4.6 | 63,482 | Common Stock |
| Candel Therapeutics Inc | Garrett Nichols William | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 10,875 | 114,482 | - | 6.5 | 70,390 | Common Stock |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 9,769 | 125,357 | - | 6.0 | 58,354 | Common Stock |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 58,479 | 58,479 | - | 0 | Common Stock | |
| Candel Therapeutics Inc | William Garrett Nichols | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges